World

Anti-corruption rally held against Serbian govt after accident

Nov 13, 2024

Belgrade [Serbia], November 13: Thousands of people took to the streets of the Serbian capital Belgrade on Monday evening, media reports said, under the slogan "Corruption Kills!" Their protest was directed against the government of President Aleksandar Vucic, following the collapse of the main railway station's canopy in the northern Serbian city of Novi Sad 10 days ago.
Fourteen people died and dozens more were injured in the canopy collapse. To this day, there is no conclusive explanation for the cause of the disaster.
Government critics assert that there is corruption among those in power, which also characterizes numerous other areas of public life in Serbia.
The station building in Novi Sad dates back to 1964 and underwent extensive renovations in recent years. However, the station's canopy was not included in these renovations, and the reasons for this are unclear.
Vucic has been ruling Serbia in various capacities, sometimes in an authoritarian manner, for 12 years.
The demonstrators marched from the government office in the centre of Belgrade to the presidential office just a few hundred metres away. The opposition parties had called for the rally.
Vucic was attending the UN Climate Change Conference in Baku at the time. Since the disaster in Novi Sad, there have already been demonstrations in the northern Serbian city and in Belgrade.
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025